Brought to you by 
Broadvector withdraws IPO on the Australian Stock Exchange
20 Dec 2010
Executive Summary
Broadvector Ltd. (gene therapies for conditions that occur with aging) has filed for its initial public offering on the Australian Stock Exchange. In an open offer, the company hopes to raise A$8.5mm ($8.1mm) by selling 42.5mm new shares at A$0.20 apiece. For every four shares issued, Broadvector will grant one option.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Gene Therapy, Cell Therapy
Deal Status
- Withdrawn
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Broadvector withdraws IPO on the Australian Stock Exchange
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice